Healthcare Analysts, along with Drs. Frank Tarazi and Friedland discuss the upcoming Clinical Trials in Alzheimer’s Disease (CTAD) Meeting and Eisai and Biogen’s Lecanemab in the first of two Analyst/Industry conference calls to be held on December 1.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ESALY: